If you are in the habit of getting vaccinated for shingles, you may be forced to wait. Shingrix — which is the vaccine for shingles prevention — has been such a sought after thing that its maker, Glaxo-SmithKline hasn’t been able to produce enough supply to keep up with the demand.
This particular vaccine is recommended for those older than 50, but many who are over 50 are having trouble getting it. There are allegedly no manufacturing problems, the company just wasn’t expecting so many people to want it.
Many individuals are desperately trying to avoid shingles, since it causes a rash that can be extremely painful, itchy and even in some cases debilitating. Sometimes it even leaves long-lasting nerve damage for months or years after contracting it.
Shingles comes from the childhood virus chicken pox, which goes dormant for years, until reactivated sometime after the age of 50 usually. 1 in 3 people are likely to have it at some point in their lives, and it can be reoccurring.
Studies have shown that two vaccinations between two to six months apart were more than 90% effective at preventing the rash, and almost 90% effective at preventing nerve complications.
Talk to your doctor to see if it is available, or how long the wait list is for the vaccine should you so desire it.
Article Originally Posted in the New York Times
Original wording changed for reposting purposes